75 related articles for article (PubMed ID: 36440412)
1. Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior.
Lagerberg T; Sjölander A; Gibbons RD; Quinn PD; D'Onofrio BM; Hellner C; Lichtenstein P; Fazel S; Chang Z
Front Psychiatry; 2022; 13():1012650. PubMed ID: 36440412
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study.
Lagerberg T; Fazel S; Sjölander A; Hellner C; Lichtenstein P; Chang Z
Neuropsychopharmacology; 2022 Mar; 47(4):817-823. PubMed ID: 34561608
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
Tundo A; de Filippis R; Proietti L
World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
[TBL] [Abstract][Full Text] [Related]
4. Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulation.
Lagerberg T; Matthews AA; Zhu N; Fazel S; Carrero JJ; Chang Z
Neuropsychopharmacology; 2023 Nov; 48(12):1760-1768. PubMed ID: 37507510
[TBL] [Abstract][Full Text] [Related]
5. Interaction between tramadol and selective serotonin reuptake inhibitors: are doctors aware of potential risks in their prescription practice?
Spies PE; Pot JLWH; Willems RPJ; Bos JM; Kramers C
Eur J Hosp Pharm; 2017 Mar; 24(2):124-127. PubMed ID: 31156918
[TBL] [Abstract][Full Text] [Related]
6. Predicting risk of suicidal behaviour after initiation of selective serotonin reuptake inhibitors in children, adolescents and young adults: protocol for development and validation of clinical prediction models.
Lagerberg T; Virtanen S; Kuja-Halkola R; Hellner C; Lichtenstein P; Fazel S; Chang Z
BMJ Open; 2023 Aug; 13(8):e072834. PubMed ID: 37612105
[TBL] [Abstract][Full Text] [Related]
7. Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study.
Reis M; Källén B
BMJ Open; 2013; 3(2):. PubMed ID: 23427202
[TBL] [Abstract][Full Text] [Related]
8. Appraisal of the methodological quality and summary of the findings of systematic reviews on the relationship between SSRIs and suicidality.
Li W; Li W; Wan Y; Ren J; Li T; Li C
Shanghai Arch Psychiatry; 2014 Oct; 26(5):248-58. PubMed ID: 25477718
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine augmentation for selective serotonin reuptake inhibitor-induced sexual dysfunction: a retropective investigation.
Atmaca M; Korkmaz S; Topuz M; Mermi O
Psychiatry Investig; 2011 Mar; 8(1):55-7. PubMed ID: 21519537
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant Use and Suicide Rates in Adults Aged 75 and Above: A Swedish Nationwide Cohort Study.
Hedna K; Fastbom J; Erlangsen A; Waern M
Front Public Health; 2021; 9():611559. PubMed ID: 33681129
[No Abstract] [Full Text] [Related]
11. CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study.
Olbrich S; Tränkner A; Surova G; Gevirtz R; Gordon E; Hegerl U; Arns M
J Psychiatr Res; 2016 Feb; 73():108-15. PubMed ID: 26714202
[TBL] [Abstract][Full Text] [Related]
12. Suicide-related events in young people following prescription of SSRIs and other antidepressants: a self-controlled case series analysis.
Wijlaars LP; Nazareth I; Whitaker HJ; Evans SJ; Petersen I
BMJ Open; 2013 Sep; 3(9):e003247. PubMed ID: 24056479
[TBL] [Abstract][Full Text] [Related]
13. Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP.
Haeberle A; Greil W; Russmann S; Grohmann R
BMC Psychiatry; 2012 Sep; 12():153. PubMed ID: 22998655
[TBL] [Abstract][Full Text] [Related]
14. A study to understand the pattern of hyponatremia in patients using selective serotonin reuptake inhibitors and serotonin dopamine antagonists.
Tomar LK; Patra P; Nigam A
Ind Psychiatry J; 2021; 30(1):113-117. PubMed ID: 34483534
[TBL] [Abstract][Full Text] [Related]
15. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer.
Ashbury JE; Lévesque LE; Beck PA; Aronson KJ
Front Oncol; 2012; 2():177. PubMed ID: 23227451
[TBL] [Abstract][Full Text] [Related]
16. Risk of Suicidal Behaviors and Antidepressant Exposure Among Children and Adolescents: A Meta-Analysis of Observational Studies.
Li K; Zhou G; Xiao Y; Gu J; Chen Q; Xie S; Wu J
Front Psychiatry; 2022; 13():880496. PubMed ID: 35693956
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved.
Renoir T
Front Pharmacol; 2013; 4():45. PubMed ID: 23596418
[TBL] [Abstract][Full Text] [Related]
19. Time to response in panic disorder in a naturalistic setting: combination therapy with alprazolam orally disintegrating tablets and serotonin reuptake inhibitors compared to serotonin reuptake inhibitors alone.
Katzelnick DJ; Saidi J; Vanelli MR; Jefferson JW; Harper JM; McCrary KE
Psychiatry (Edgmont); 2006 Dec; 3(12):39-49. PubMed ID: 20877555
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
